Cardiff Lexington grants 500K options to director
A Cardiff Lexington Corp director received 500,000 stock options exercisable at $0.1162, expiring in 2031.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cardiff Lexington Corp (CDIX) reported that director Johnson Gillard B. III received a grant of 500,000 stock options on September 8, 2026. The options are exercisable for Cardiff Lexington common stock at an exercise price of $0.1162 per share and expire on September 8, 2031. Following this grant, he holds 500,000 options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 500,000 | $0.00 | $0.00 |
Key Figures
Key Terms
Stock Option financial
underlying security financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CDIX disclose for Johnson Gillard B. III?
What is the exercise price of the new stock options granted at CDIX?
When do the newly granted CDIX stock options expire?
How many CDIX options does the director hold after this transaction?
Was the CDIX option grant reported under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.